Metraipolis › archive › dc_d126c46f451e

Anti-CD123 CAR-T therapy combined with autologous SCT and venetoclax maintenance in refractory BPDCN ineligible for allogeneic transplantation: a case report… — Europe PMC PMID:42602092

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42602092
DOI
10.3389/fimmu.2026.1922400
License (as archived)
solo-consultazione
Archived
2026-10-17T06:40:27.291Z
SHA-256 of the archived text
4e806f800dfc6da83e17bce2251f588af22be6186725377abc5618ca26cc4bc7
Stable URL of this page
https://metraipolis.com/documento/dc_d126c46f451e

How to cite

Anti-CD123 CAR-T therapy combined with autologous SCT and venetoclax maintenance in refractory BPDCN ineligible for allogeneic transplantation: a case report… — Europe PMC PMID:42602092 — Europe PMC (en), https://europepmc.org/article/MED/42602092 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_d126c46f451e (Metraipolis archive dc_d126c46f451e, sha256 4e806f800dfc6da83e17bce2251f588af22be6186725377abc5618ca26cc4bc7)
BibTeX
@misc{dcd126c46f451e,
  title = {Anti-CD123 CAR-T therapy combined with autologous SCT and venetoclax maintenance in refractory BPDCN ineligible for allogeneic transplantation: a case report… — Europe PMC PMID:42602092},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42602092},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_d126c46f451e; sha256 4e806f800dfc6da83e17bce2251f588af22be6186725377abc5618ca26cc4bc7},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42602092. Agents can read the archived copy with the MCP tool read_document.